Computers outperform lab rats in detecting toxic chemicals

Feb. 19, 2018

UL, the science safety company, and Johns Hopkins University have embarked on joint research that has resulted in findings that Artificial Intelligence (AI) is superior in finding toxic substances to traditional animal testing. Beyond being more effective, UL’s Cheminformatics REACHAcross software computer processing can be performed in a matter of seconds and at a fraction of the cost to traditional testing methods. Working with researchers at the Bloomberg School of Public Health, UL has developed an innovative suite of tools including REACHAcross software to predict chemical toxicity that can be used wherever such data is needed.

AI development, like predictive cheminformatics, has been slowly progressing over the last two decades. It was in 1996 that the supercomputer Deep Blue beat chess world champion Gary Kasparov for the first time by using the data from over 700,000 games to learn more than 200 million possible moves. In the infancy of AI, it was estimated that Deep Blue cost more than $12 million.

Today, similar computing power is accessible with far more affordable systems, allowing the use of AI for real-world problems, like predicting toxicity. There are more than 100,000 chemicals in medications and consumer products; for the vast majority; there is very little information about their toxicity. Dr. Thomas Hartung, Chair for Evidence-based Toxicology at Johns Hopkins University, wants “to help end toxicological ignorance”, asserting that “we will not succeed if we continue using antiquated methods like animal testing, which has been in use since the beginning of biomedical research.” To that end, his group at Johns Hopkins University, led by Tom Luechtefeld, created a database—not of chess moves—but, of toxicity studies. In 2016, when revealed at The American Association for the Advancement of Science (AAAS), the groundbreaking breadth of the REACHAcross software database (with 800,000 toxicological studies for over 10,000 chemicals) created the basis for using Big Data in safety assessments.

In collaboration with UL, the database has expanded to over 70 million chemical structures, containing more than 300,000 biological data points and 20,000 animal data points. Regretfully, the database reflects that many chemicals have been tested multiple times, causing unnecessary loss of animal life. For instance, the six most frequently performed animal toxicity tests comprised over half of all animal testing casualties in Europe in 2011. When the reproducibility of these tests was analyzed, the results also raise strong concerns—when a toxic substance is tested a second time with the same test method, the results will only be repeatable in 70% of cases.

UL Cheminformatics, however, processes an untested chemical by identifying the most similar chemicals in half a second, while performing about 500 million calculations—just like Deep Blue found possible chess moves. The first module in the UL Cheminformatics suite, REACHAcross software, utilizes an advanced, predictive algorithm, as well as machine learning, to assess the toxicity of any chemical. By analyzing billions of chemical combinations, REACHAcross software can predict potentially harmful health and environmental effects of chemicals, including skin sensitization, acute oral and dermal toxicity, eye and dermal irritation, mutagenicity and acute and chronic aquatic toxicity.

EurekAlert! has the full story

Sponsored Recommendations

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

TEST: Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

From Strategy to Action: The Power of Enterprise Value-Based Care

Ever wonder why your meticulously planned value-based care model hasn't moved beyond the concept stage? You're not alone! Transition from theory to practice with enterprise value...